GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹7,486 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr |
What is the latest Appropriations of GLAND PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹7,486 Cr |
| Mar2025 | ₹6,788 Cr |
| Mar2024 | ₹6,015 Cr |
| Mar2023 | ₹5,234 Cr |
| Mar2022 | ₹4,023 Cr |
How is Appropriations of GLAND PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,486 Cr | 10.29 | |
| Mar2025 | ₹6,788 Cr | 12.84 | |
| Mar2024 | ₹6,015 Cr | 14.92 | |
| Mar2023 | ₹5,234 Cr | 30.12 | |
| Mar2022 | ₹4,023 Cr | - | |
Compare Appropriations of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹49,311.9 Cr | 2.8% | 3.6% | 43.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.8% |
3.6% |
43.5% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses